US20220177639A1 - Latent curing catalysts and resin composition containing the same - Google Patents
Latent curing catalysts and resin composition containing the same Download PDFInfo
- Publication number
- US20220177639A1 US20220177639A1 US17/609,365 US202017609365A US2022177639A1 US 20220177639 A1 US20220177639 A1 US 20220177639A1 US 202017609365 A US202017609365 A US 202017609365A US 2022177639 A1 US2022177639 A1 US 2022177639A1
- Authority
- US
- United States
- Prior art keywords
- fine particles
- resin composition
- curing
- zirconium phosphate
- curing accelerator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003054 catalyst Substances 0.000 title claims abstract description 61
- 239000011342 resin composition Substances 0.000 title claims description 59
- 229910000166 zirconium phosphate Inorganic materials 0.000 claims abstract description 105
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 claims abstract description 104
- 239000010419 fine particle Substances 0.000 claims abstract description 89
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 19
- 125000001475 halogen functional group Chemical group 0.000 claims abstract 2
- 239000003822 epoxy resin Substances 0.000 claims description 43
- 229920000647 polyepoxide Polymers 0.000 claims description 43
- 239000002904 solvent Substances 0.000 claims description 36
- -1 zirconium alkoxide Chemical class 0.000 claims description 32
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 21
- 150000004665 fatty acids Chemical class 0.000 claims description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 18
- 229930195729 fatty acid Natural products 0.000 claims description 18
- 150000003754 zirconium Chemical class 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 229910052726 zirconium Inorganic materials 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 239000000853 adhesive Substances 0.000 claims description 13
- 230000001070 adhesive effect Effects 0.000 claims description 13
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 13
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 5
- TVCBSVKTTHLKQC-UHFFFAOYSA-M propanoate;zirconium(4+) Chemical compound [Zr+4].CCC([O-])=O TVCBSVKTTHLKQC-UHFFFAOYSA-M 0.000 claims description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 238000003860 storage Methods 0.000 description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 150000001412 amines Chemical class 0.000 description 9
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 229920003986 novolac Polymers 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000011229 interlayer Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 238000004627 transmission electron microscopy Methods 0.000 description 6
- ULKLGIFJWFIQFF-UHFFFAOYSA-N 5K8XI641G3 Chemical compound CCC1=NC=C(C)N1 ULKLGIFJWFIQFF-UHFFFAOYSA-N 0.000 description 5
- 229930185605 Bisphenol Natural products 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 150000002460 imidazoles Chemical class 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004593 Epoxy Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical group [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 4
- 150000008065 acid anhydrides Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- KMOUUZVZFBCRAM-OLQVQODUSA-N (3as,7ar)-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C=CC[C@@H]2C(=O)OC(=O)[C@@H]21 KMOUUZVZFBCRAM-OLQVQODUSA-N 0.000 description 3
- GIWQSPITLQVMSG-UHFFFAOYSA-N 1,2-dimethylimidazole Chemical compound CC1=NC=CN1C GIWQSPITLQVMSG-UHFFFAOYSA-N 0.000 description 3
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920001568 phenolic resin Polymers 0.000 description 3
- 239000005011 phenolic resin Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 2
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 2
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000005004 MAS NMR spectroscopy Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229930003836 cresol Natural products 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920006295 polythiol Polymers 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005011 time of flight secondary ion mass spectroscopy Methods 0.000 description 2
- 238000002042 time-of-flight secondary ion mass spectrometry Methods 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MUTGBJKUEZFXGO-OLQVQODUSA-N (3as,7ar)-3a,4,5,6,7,7a-hexahydro-2-benzofuran-1,3-dione Chemical compound C1CCC[C@@H]2C(=O)OC(=O)[C@@H]21 MUTGBJKUEZFXGO-OLQVQODUSA-N 0.000 description 1
- LDCQBHLZLZUAAF-UHFFFAOYSA-N (5-methyl-2-phenyl-1h-imidazol-4-yl)methanediol Chemical compound OC(O)C1=C(C)NC(C=2C=CC=CC=2)=N1 LDCQBHLZLZUAAF-UHFFFAOYSA-N 0.000 description 1
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- FBHPRUXJQNWTEW-UHFFFAOYSA-N 1-benzyl-2-methylimidazole Chemical compound CC1=NC=CN1CC1=CC=CC=C1 FBHPRUXJQNWTEW-UHFFFAOYSA-N 0.000 description 1
- XZKLXPPYISZJCV-UHFFFAOYSA-N 1-benzyl-2-phenylimidazole Chemical compound C1=CN=C(C=2C=CC=CC=2)N1CC1=CC=CC=C1 XZKLXPPYISZJCV-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- NBNGHXWJFSMASY-UHFFFAOYSA-N 2,3,4-tris(dimethylamino)phenol Chemical compound CN(C)C1=CC=C(O)C(N(C)C)=C1N(C)C NBNGHXWJFSMASY-UHFFFAOYSA-N 0.000 description 1
- YSUQLAYJZDEMOT-UHFFFAOYSA-N 2-(butoxymethyl)oxirane Chemical compound CCCCOCC1CO1 YSUQLAYJZDEMOT-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical group ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- JPEGUDKOYOIOOP-UHFFFAOYSA-N 2-(hexoxymethyl)oxirane Chemical compound CCCCCCOCC1CO1 JPEGUDKOYOIOOP-UHFFFAOYSA-N 0.000 description 1
- LSWYGACWGAICNM-UHFFFAOYSA-N 2-(prop-2-enoxymethyl)oxirane Chemical compound C=CCOCC1CO1 LSWYGACWGAICNM-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- FUIQBJHUESBZNU-UHFFFAOYSA-N 2-[(dimethylazaniumyl)methyl]phenolate Chemical compound CN(C)CC1=CC=CC=C1O FUIQBJHUESBZNU-UHFFFAOYSA-N 0.000 description 1
- CQOZJDNCADWEKH-UHFFFAOYSA-N 2-[3,3-bis(2-hydroxyphenyl)propyl]phenol Chemical compound OC1=CC=CC=C1CCC(C=1C(=CC=CC=1)O)C1=CC=CC=C1O CQOZJDNCADWEKH-UHFFFAOYSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- YMJPBYVLNFBSFE-UHFFFAOYSA-N 2-ethyl-4-methylimidazole-1-carbonitrile Chemical compound CCC1=NC(C)=CN1C#N YMJPBYVLNFBSFE-UHFFFAOYSA-N 0.000 description 1
- YTWBFUCJVWKCCK-UHFFFAOYSA-N 2-heptadecyl-1h-imidazole Chemical compound CCCCCCCCCCCCCCCCCC1=NC=CN1 YTWBFUCJVWKCCK-UHFFFAOYSA-N 0.000 description 1
- LDZYRENCLPUXAX-UHFFFAOYSA-N 2-methyl-1h-benzimidazole Chemical compound C1=CC=C2NC(C)=NC2=C1 LDZYRENCLPUXAX-UHFFFAOYSA-N 0.000 description 1
- VTRGMFPXUFRLKC-UHFFFAOYSA-N 2-methylimidazole-1-carbonitrile Chemical compound CC1=NC=CN1C#N VTRGMFPXUFRLKC-UHFFFAOYSA-N 0.000 description 1
- ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 2-phenyl-1h-imidazole Chemical compound C1=CNC(C=2C=CC=CC=2)=N1 ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 0.000 description 1
- BKCCAYLNRIRKDJ-UHFFFAOYSA-N 2-phenyl-4,5-dihydro-1h-imidazole Chemical compound N1CCN=C1C1=CC=CC=C1 BKCCAYLNRIRKDJ-UHFFFAOYSA-N 0.000 description 1
- UCCGHLMDDOUWAF-UHFFFAOYSA-N 2-phenylimidazole-1-carbonitrile Chemical compound N#CN1C=CN=C1C1=CC=CC=C1 UCCGHLMDDOUWAF-UHFFFAOYSA-N 0.000 description 1
- LLEASVZEQBICSN-UHFFFAOYSA-N 2-undecyl-1h-imidazole Chemical compound CCCCCCCCCCCC1=NC=CN1 LLEASVZEQBICSN-UHFFFAOYSA-N 0.000 description 1
- XZWHGXOBJHTMTK-UHFFFAOYSA-N 2-undecylimidazole-1-carbonitrile Chemical compound CCCCCCCCCCCC1=NC=CN1C#N XZWHGXOBJHTMTK-UHFFFAOYSA-N 0.000 description 1
- VEORPZCZECFIRK-UHFFFAOYSA-N 3,3',5,5'-tetrabromobisphenol A Chemical compound C=1C(Br)=C(O)C(Br)=CC=1C(C)(C)C1=CC(Br)=C(O)C(Br)=C1 VEORPZCZECFIRK-UHFFFAOYSA-N 0.000 description 1
- XYXBMCIMPXOBLB-UHFFFAOYSA-N 3,4,5-tris(dimethylamino)-2-methylphenol Chemical compound CN(C)C1=CC(O)=C(C)C(N(C)C)=C1N(C)C XYXBMCIMPXOBLB-UHFFFAOYSA-N 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical compound C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- WVRNUXJQQFPNMN-VAWYXSNFSA-N 3-[(e)-dodec-1-enyl]oxolane-2,5-dione Chemical compound CCCCCCCCCC\C=C\C1CC(=O)OC1=O WVRNUXJQQFPNMN-VAWYXSNFSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- RDNPPYMJRALIIH-UHFFFAOYSA-N 3-methylcyclohex-3-ene-1,1,2,2-tetracarboxylic acid Chemical compound CC1=CCCC(C(O)=O)(C(O)=O)C1(C(O)=O)C(O)=O RDNPPYMJRALIIH-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- ODJUOZPKKHIEOZ-UHFFFAOYSA-N 4-[2-(4-hydroxy-3,5-dimethylphenyl)propan-2-yl]-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=C(C)C=2)=C1 ODJUOZPKKHIEOZ-UHFFFAOYSA-N 0.000 description 1
- WFCQTAXSWSWIHS-UHFFFAOYSA-N 4-[bis(4-hydroxyphenyl)methyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 WFCQTAXSWSWIHS-UHFFFAOYSA-N 0.000 description 1
- KGYYLUNYOCBBME-UHFFFAOYSA-M 4-fluoro-2-phenyl-4-(4-propylcyclohexyl)cyclohexa-1,5-diene-1-carboxylate Chemical compound C1CC(CCC)CCC1C1(F)C=CC(C([O-])=O)=C(C=2C=CC=CC=2)C1 KGYYLUNYOCBBME-UHFFFAOYSA-M 0.000 description 1
- VQVIHDPBMFABCQ-UHFFFAOYSA-N 5-(1,3-dioxo-2-benzofuran-5-carbonyl)-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)=O)=C1 VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 1
- TYOXIFXYEIILLY-UHFFFAOYSA-N 5-methyl-2-phenyl-1h-imidazole Chemical compound N1C(C)=CN=C1C1=CC=CC=C1 TYOXIFXYEIILLY-UHFFFAOYSA-N 0.000 description 1
- 102100027123 55 kDa erythrocyte membrane protein Human genes 0.000 description 1
- MWSKJDNQKGCKPA-UHFFFAOYSA-N 6-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1CC(C)=CC2C(=O)OC(=O)C12 MWSKJDNQKGCKPA-UHFFFAOYSA-N 0.000 description 1
- GOYGTBXFJBGGLI-UHFFFAOYSA-N 7a-but-1-enyl-3a-methyl-4,5-dihydro-2-benzofuran-1,3-dione Chemical compound C1=CCCC2(C)C(=O)OC(=O)C21C=CCC GOYGTBXFJBGGLI-UHFFFAOYSA-N 0.000 description 1
- YWFPGFJLYRKYJZ-UHFFFAOYSA-N 9,9-bis(4-hydroxyphenyl)fluorene Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C2=CC=CC=C21 YWFPGFJLYRKYJZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000015866 Citrullus vulgaris var fistulosus Nutrition 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 101001057956 Homo sapiens 55 kDa erythrocyte membrane protein Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- KYPYTERUKNKOLP-UHFFFAOYSA-N Tetrachlorobisphenol A Chemical compound C=1C(Cl)=C(O)C(Cl)=CC=1C(C)(C)C1=CC(Cl)=C(O)C(Cl)=C1 KYPYTERUKNKOLP-UHFFFAOYSA-N 0.000 description 1
- 241000241474 Tinda Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- JOBBTVPTPXRUBP-UHFFFAOYSA-N [3-(3-sulfanylpropanoyloxy)-2,2-bis(3-sulfanylpropanoyloxymethyl)propyl] 3-sulfanylpropanoate Chemical compound SCCC(=O)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS JOBBTVPTPXRUBP-UHFFFAOYSA-N 0.000 description 1
- UUQQGGWZVKUCBD-UHFFFAOYSA-N [4-(hydroxymethyl)-2-phenyl-1h-imidazol-5-yl]methanol Chemical compound N1C(CO)=C(CO)N=C1C1=CC=CC=C1 UUQQGGWZVKUCBD-UHFFFAOYSA-N 0.000 description 1
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical group O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 1
- FLBJFXNAEMSXGL-UHFFFAOYSA-N het anhydride Chemical compound O=C1OC(=O)C2C1C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl FLBJFXNAEMSXGL-UHFFFAOYSA-N 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- VYKXQOYUCMREIS-UHFFFAOYSA-N methylhexahydrophthalic anhydride Chemical compound C1CCCC2C(=O)OC(=O)C21C VYKXQOYUCMREIS-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NXPPAOGUKPJVDI-UHFFFAOYSA-N naphthalene-1,2-diol Chemical compound C1=CC=CC2=C(O)C(O)=CC=C21 NXPPAOGUKPJVDI-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- JKXONPYJVWEAEL-UHFFFAOYSA-N oxiran-2-ylmethyl acetate Chemical compound CC(=O)OCC1CO1 JKXONPYJVWEAEL-UHFFFAOYSA-N 0.000 description 1
- XRQKARZTFMEBBY-UHFFFAOYSA-N oxiran-2-ylmethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1CO1 XRQKARZTFMEBBY-UHFFFAOYSA-N 0.000 description 1
- YLNSNVGRSIOCEU-UHFFFAOYSA-N oxiran-2-ylmethyl butanoate Chemical compound CCCC(=O)OCC1CO1 YLNSNVGRSIOCEU-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- 125000005591 trimellitate group Chemical group 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- LJQSESUEJXAKBR-UHFFFAOYSA-J zirconium(4+) tetrachloride octahydrate Chemical compound O.O.O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cl-].[Zr+4] LJQSESUEJXAKBR-UHFFFAOYSA-J 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
- C08G59/688—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/4007—Curing agents not provided for by the groups C08G59/42 - C08G59/66
- C08G59/4071—Curing agents not provided for by the groups C08G59/42 - C08G59/66 phosphorus containing compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/06—Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
- B01J21/066—Zirconium or hafnium; Oxides or hydroxides thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/14—Phosphorus; Compounds thereof
- B01J27/16—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/14—Phosphorus; Compounds thereof
- B01J27/16—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr
- B01J27/18—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr with metals other than Al or Zr
-
- B01J35/023—
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/20—Catalysts, in general, characterised by their form or physical properties characterised by their non-solid state
- B01J35/23—Catalysts, in general, characterised by their form or physical properties characterised by their non-solid state in a colloidal state
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/40—Catalysts, in general, characterised by their form or physical properties characterised by dimensions, e.g. grain size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
- B01J37/28—Phosphorising
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/4007—Curing agents not provided for by the groups C08G59/42 - C08G59/66
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
- C08G59/686—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J163/00—Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2363/00—Characterised by the use of epoxy resins; Derivatives of epoxy resins
Definitions
- the present invention relates to a latent curing catalyst, a resin composition containing the catalyst, and a method for producing zirconium phosphate fine particles containing a curing accelerator.
- Alpha-zirconium phosphate forms a layered structure by cross-linking phosphates pairs above and below the zirconium atom surface. It is known that zirconium phosphate can intercalate basic compounds such as amine compounds into the interlayer by utilizing the properties of the phosphate groups in the interlayer as solid acids (see, for example, Non-Patent Documents 1 and 2).
- Various types of latent curing catalysts have been developed, and it has been reported that an amine compound used as an epoxy resin curing accelerator is intercalated between the layers of layered zirconium phosphate to be used as a latent curing catalyst that does not react with the resin under one-component storage conditions, i.e., the reaction does not proceed under storage conditions and is inactive, but proceeds only under heating conditions (see, for example, Patent Documents 1 to 5).
- the present invention addresses the problem of providing a latent curing catalyst having excellent storage stability and capable of performing a curing reaction at a low temperature of less than 100° C., and a resin composition containing the catalyst.
- the first embodiment of the present invention is a latent curing catalyst including zirconium phosphate fine particles containing a curing accelerator, wherein the zirconium phosphate fine particles containing the curing accelerator do not have a sharp crystalline peak at a diffraction angle (2 ⁇ ) in a range of 10° to 40° in powder X-ray diffraction and have a broad halo pattern.
- the second embodiment of the present invention is a resin composition containing (A) an epoxy resin and (B) the latent curing catalyst of the first embodiment.
- the third embodiment of the present invention is an adhesive containing the resin composition of the second embodiment.
- the fourth embodiment of the present invention is a film containing the resin composition of the second embodiment.
- the fifth embodiment of the present invention is a cured product obtained by curing the resin composition of the second embodiment.
- the sixth embodiment of the present invention is a method for producing a cured product, including a step of curing the resin composition of the second embodiment.
- the seventh embodiment of the present invention is a method for producing zirconium phosphate fine particles containing a curing accelerator, including:
- step (b) mixing the solution obtained in the step (a) with phosphoric acid to obtain zirconium phosphate fine particles;
- a latent curing catalyst having excellent storage stability and capable of performing curing reactions at low temperatures of less than 100° C., a resin composition containing the catalyst, and an adhesive and a film containing the resin composition.
- the zirconium phosphate fine particles containing the curing accelerator as a latent curing catalyst have a very small average particle diameter, which allows them to penetrate into narrow gaps and can be used for bonding and sealing of narrow gaps.
- the present invention it is possible to provide a latent curing catalyst, a resin composition containing the catalyst, and an adhesive and a film containing the resin composition, which have excellent storage stability, can perform curing reactions at low temperatures of less than 100° C., and can be used for bonding and sealing of narrow gaps.
- the present invention also provides a method for producing zirconium phosphate fine particles containing a curing accelerator that can be used as a latent curing catalyst that has excellent storage stability and can perform curing reactions at low temperatures of less than 100° C.
- FIG. 1 shows powder X-ray diffraction patterns of zirconium phosphate fine particles containing a curing accelerator in Example A.
- FIG. 1-1 shows a powder X-ray diffraction pattern of zirconium phosphate fine particles containing a curing accelerator with solvent.
- FIG. 1-2 shows a powder X-ray diffraction pattern of zirconium phosphate fine particles containing a curing accelerator with the solvent removed.
- FIG. 2 shows a TEM photograph of zirconium phosphate fine particles containing a curing accelerator in Example A, taken over an arbitrary area of about 400 nm ⁇ 600 nm.
- FIG. 3 shows a powder X-ray diffraction pattern of amine-containing zirconium phosphate crystalline particles produced according to the method described in Japanese Patent Application Kokai Publication No. 2014-101397.
- the first embodiment of the present invention is a latent curing catalyst including zirconium phosphate fine particles containing a curing accelerator, wherein the zirconium phosphate fine particles containing the curing accelerator do not have a sharp crystalline peak at a diffraction angle (2 ⁇ ) in a range of 10° to 40° in powder X-ray diffraction and have a broad halo pattern.
- zirconium phosphate fine particles containing a curing accelerator can be used directly as a latent curing catalyst.
- the latent curing catalyst of this embodiment has excellent storage stability and can perform curing reactions at low temperatures of less than 100° C.
- the average particle diameter of the latent curing catalyst is very small, it can penetrate into narrow gaps and can be used for bonding and sealing of narrow gaps.
- the zirconium phosphate fine particles containing a curing accelerator in this embodiment have low crystallinity and a broad halo pattern in powder X-ray diffraction without a sharp crystalline peak at a diffraction angle (2 ⁇ ) in a range of 10° to 40°.
- it shows a powder X-ray diffraction pattern which is substantially identical to FIG. 1 .
- the diffraction peak intensities in the experimental pattern can be different and may vary due to the preferred orientation in the prepared sample, as is well known in the art.
- Conventional layered zirconium phosphate with intercalated curing accelerators between the layers can be obtained, for example, by mixing layered zirconium phosphate with a curing accelerator and reacting at room temperature to 40° C. for 1 hour to 1 month (see, for example, Japanese Patent Application Kokai Publication No. 2014-101397).
- Zirconium phosphate with a layered structure has a uniform interlayer distance and high crystallinity (see FIG. 3 ).
- the particle diameter of zirconium phosphate with a layered structure can be controlled by its production method, and the particle diameter on the plate surface is usually 1 ⁇ m to 100 ⁇ m (in addition, zirconium phosphate with a layered structure usually takes the form of flat particles).
- Zirconium phosphate with a layered structure can be produced, for example, by mixing and reacting zirconium chloride octahydrate with an aqueous phosphoric acid solution (L. Sun, W. J. Boo, H.-J. Sue, A. Clearfield, New J. Chem., 31, 39 (2007)).
- the zirconium phosphate fine particles containing a curing accelerator in the present invention can be obtained by mixing zirconium phosphate fine particles with the curing accelerator.
- the external temperature is not limited, and for example, it can be carried out at room temperature to 40° C.
- zirconium phosphate fine particles can be obtained, for example, by dissolving a zirconium salt of a fatty acid or a zirconium alkoxide in a solvent to obtain a solution, and then mixing the solution with phosphoric acid.
- the zirconium phosphate fine particles obtained in this way have a layered structure, their interlayer distance is wide, their crystallinity is low, and their average particle diameter is 1 nm to 500 nm. It is thought that the low crystallinity of the zirconium phosphate fine particles in the zirconium phosphate fine particles containing a curing accelerator in the present invention makes it easy for the curing accelerator intercalated between the layers to be activated, and for example, even low-temperature thermal stimulation of 60° C. or higher, preferably 70° C. or higher, and more preferably 80° C. or higher activates the curing accelerator, allowing the curing reaction to take place at low temperatures.
- the zirconium phosphate fine particles containing a curing accelerator in the present invention have a very small average particle diameter of 1 nm to 500 nm, so they can penetrate into narrow gaps and can be used for bonding and sealing of narrow gaps.
- the method for producing zirconium phosphate fine particles containing a curing accelerator in the present invention includes the following steps:
- step (b) mixing the solution obtained in the step (a) with phosphoric acid to obtain zirconium phosphate fine particles;
- a method for producing zirconium phosphate fine particles containing a curing accelerator is an embodiment of the present invention.
- a zirconium salt of a fatty acid or a zirconium alkoxide is dissolved in a solvent to obtain a solution.
- the zirconium salt of fatty acid is zirconium salts of fatty acids, and can be zirconium salts of mono-fatty acids or zirconium salts of poly-fatty acids such as di-fatty acids.
- the fatty acids are preferably fatty acids with 1 to 6 carbon atoms, such as acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, valeric acid, caproic acid, and lactic acid.
- the zirconium salt of fatty acid is preferably zirconium propionate.
- the zirconium alkoxide is represented by the formula:
- R 1 is independently methyl, ethyl, n-propyl, i-propyl, n-butyl, and tert-butyl.
- Solvents can be any solvents in which zirconium salts of fatty acids or zirconium alkoxides can be dissolved, and examples thereof may include alcohols such as methanol, ethanol, propanol, and butanol; esters such as ethyl acetate and methyl acetate; ketones such as acetone and 2-butanone; ethers such as diethyl ether, dimethyl ether, diisopropyl ether, and tetrahydrofuran; amides such as dimethylformamide and dimethylacetamide; dimethyl sulfoxide, N-methylpyrrolidone, acetonitrile, chloroform, dichloromethane, etc.; and mixtures of these solvents. Of these, alcohols or esters are preferred.
- the solution obtained in the step (a) above is mixed with phosphoric acid to obtain zirconium phosphate fine particles.
- the molar ratio of zirconium to phosphoric acid in zirconium phosphate fine particles can be adjusted depending on the amount of phosphoric acid used, and the amount of phosphoric acid used is, for example, 1 mol or more, preferably 2 mol or more, and 10 mol or less, preferably 7 mol or less with respect to 1 mol of zirconium salt of fatty acid or zirconium alkoxide.
- the mixing of the solution obtained in the step (a) with phosphoric acid is performed, for example, by adding phosphoric acid to the solution obtained in the step (a) and stirring.
- zirconium phosphate fine particles are precipitated as a transparent gel-like substance.
- the precipitated zirconium phosphate fine particles contain the solvent used for production. If necessary, the precipitated zirconium phosphate fine particles may be washed and the aforementioned solvent may be replaced with other solvents.
- alkanes such as hexane and heptane
- aromatic hydrocarbons such as benzene and toluene
- the solvent containing zirconium phosphate fine particles can be used as a medium containing zirconium phosphate fine particles used in the next step (c).
- a medium containing the zirconium phosphate fine particles and a curing accelerator are mixed to obtain zirconium phosphate fine particles containing the curing accelerator.
- the mixing of the medium containing the zirconium phosphate fine particles and the curing accelerator can be performed, for example, by adding the curing accelerator dissolved in a solvent to the medium containing the zirconium phosphate fine particles and stirring for 30 minutes to 24 hours.
- alkanes such as hexane and heptane, and aromatic hydrocarbons such as benzene and toluene can be used as solvents to dissolve the curing accelerator, but preferably the same medium as the medium containing the zirconium phosphate fine particles is used.
- the zirconium phosphate fine particles containing the curing accelerator can be obtained by separating from the medium and washing with an appropriate solvent. In this state, the zirconium phosphate fine particles containing the curing accelerator are a gel-like substance containing a solvent, and the solvent in the zirconium phosphate fine particles containing the curing accelerator can be removed by drying if necessary.
- Zirconium phosphate fine particles containing a curing accelerator can be used as a latent curing catalyst in either the solvent-containing state or the solvent-removed state.
- Zirconium phosphate fine particles can contain curing accelerators, usually up to one equivalent of saturation with respect to one equivalent of phosphate groups in zirconium phosphate fine particles. Therefore, when mixing the medium containing zirconium phosphate fine particles and the curing accelerator, the amount of curing accelerator used is preferably 0.5 to 1.5 equivalents with respect to one equivalent of phosphate group of zirconium phosphate fine particles.
- This can produce a latent curing catalyst that contains 1 to 50% by mass of the curing accelerator.
- the curing accelerator is an amine compound
- the content (% by mass) of the amine compound in the latent curing catalyst can be calculated by determining the mass of nitrogen atoms contained in the dried latent curing catalyst using an elemental analyzer.
- the curing accelerator in zirconium phosphate fine particles containing the curing accelerator is one that lowers the activation energy of the curing reaction of epoxy resins, and any compound known as a curing accelerator for epoxy resins can be used. Of these, curing accelerators with basic properties are preferred because they have a greater effect on the storage stability of the resin composition.
- curing accelerators may include imidazole compounds such as imidazole, 2-methylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, 2-phenylimidazole, benzimidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-methylimidazole, 1-benzyl-2-phenylimidazole, 1-cyano-2-methylimidazole, 1-cyano-2-undecylimidazole, 1-cyano-2-ethyl-4-methylimidazole, 1-cyano-2-phenylimidazole, 2,4-diamino-6-[2′-methylimidazolyl-(1′)]-ethyl-s-triazine, 2,4-diamino-6-[2′-undecylimidazolyl-(1′)]
- the curing accelerator in the present invention is preferably a curing accelerator having a basic property, more preferably imidazole compounds, and even more preferably 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, and 2-methylimidazole.
- the zirconium phosphate fine particles containing the curing accelerator in this embodiment have an average particle diameter of the primary particles of 1 nm to 500 nm, preferably 5 nm to 450 nm, and more preferably 10 nm to 400 nm.
- the average particle diameter of zirconium phosphate fine particles containing a curing accelerator is the average value obtained when the particle diameter of a plate surface (long axis length of the plate surface) of each of 20 arbitrary particles is measured by transmission electron microscopy (TEM).
- TEM transmission electron microscopy
- the shape of the zirconium phosphate fine particles containing the curing accelerator is not particularly limited, but usually takes the form of flat particles.
- the zirconium phosphate fine particles containing the curing accelerator of the present invention contain some zirconium salts of fatty acids or zirconium alkoxides used as raw materials in their manufacture. This is thought to cause the interlayer distance of zirconium phosphate fine particles to become uneven and wide, resulting in low crystallinity.
- the amount of zirconium salts of fatty acids or zirconium alkoxides in the zirconium phosphate fine particles containing the curing accelerator is, for example, 0.01 mol to 0.8 mol, preferably 0.05 mol to 0.5 mol, with respect to 1 mol of zirconium in the zirconium phosphate fine particles.
- the presence and amount of zirconium salts of fatty acids or zirconium alkoxides in the zirconium phosphate fine particles containing the curing accelerator can be determined by, for example, time-of-flight secondary ion mass spectrometry (TOF-SIMS) or magic angle spinning (MAS) nuclear magnetic resonance spectroscopy (NMR).
- TOF-SIMS time-of-flight secondary ion mass spectrometry
- MAS magic angle spinning nuclear magnetic resonance spectroscopy
- the second embodiment of the present invention is a one-component epoxy resin composition containing (a) an epoxy resin and (b) the latent curing catalyst of the first embodiment.
- the epoxy resin in the present invention is one in which one carbon atom of the epoxy ring is a primary carbon atom from the viewpoint of reactivity with curing accelerators.
- the epoxy resin is preferably liquid at ordinary temperature (25° C. ⁇ 5° C.). However, it is also possible to dilute the epoxy resin, which is solid at ordinary temperature, with a diluent or the like to make it liquid for use.
- the (A) epoxy resin can be either a monoepoxy compound, a polyvalent epoxy compound, or a mixture thereof.
- Monoepoxy compounds may include, for example, glycidylbutyl ether, glycidylhexyl ether, glycidylphenyl ether, glycidylallyl ether, glycidyl para-tert-butylphenyl ether, ethylene oxide, propylene oxide, paraxylyl glycidyl ether, glycidyl acetate, glycidyl butyrate, glycidyl hexoate, glycidyl benzoate, and the like.
- Polyvalent epoxy compounds may include, for example, bisphenol type epoxy resins made by glycidylating bisphenols such as bisphenol A, bisphenol F, bisphenol AD, bisphenol S, tetramethylbisphenol A, tetramethylbisphenol F, tetramethylbisphenol AD, tetramethylbisphenol S, tetrabromobisphenol A, tetrachlorobisphenol A, and tetrafluorobisphenol A; epoxy resins made by glycidylating other divalent phenols such as biphenol, dihydroxynaphthalene, and 9,9-bis(4-hydroxyphenyl)fluorene; epoxy resins made by glycidylating trisphenols such as 1,1,1-tris(4-hydroxyphenyl)methane, and 4,4-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; epoxy resins made by glycidy
- the content of the (A) epoxy resin in the resin composition of the present invention is preferably 2 to 80% by mass, more preferably 2.5 to 70% by mass, and even more preferably 3 to 60% by mass.
- the content of the (A) epoxy resin in the resin composition is within the above-described range, the desired cured product can be obtained.
- a (B) latent curing catalyst in the resin composition of the second embodiment of the present invention is the latent curing catalyst of the first embodiment of the present invention.
- the curing accelerator in the (B) latent curing catalyst is preferably a curing accelerator having basic properties, more preferably imidazole compounds, and even more preferably 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, and 2-methylimidazole.
- the amount of the (B) latent curing catalyst (in a solvent-free state) in the epoxy resin composition is preferably 0.1 to 50% by mass, more preferably 1 to 45% by mass, and particularly preferably 3 to 40% by mass, with respect to the total of 100 parts by mass of components other than solid components such as fillers and pigments.
- the resin composition of the present invention may contain additives as necessary to the extent that the effects of the present invention are not impaired.
- Additives may include, for example, (C) a curing agent other than the (B) latent curing catalyst, a filler, a diluent, a solvent, a pigment, a flexibility-adding agent, a coupling agent, an antioxidant, a thixotropic agent, and a dispersing agent.
- the resin composition of the present invention can contain (C) a curing agent other than the (B) latent curing catalyst to the extent that the effects of the present invention are not impaired.
- a curing agent other than the (B) latent curing catalyst phenol type curing agents, acid anhydrides, and thiol type curing agents are mentioned.
- Phenol type curing agents refer to monomers, oligomers, and polymers in general that have phenolic hydroxyl groups. Specifically, phenol novolac resins and their alkylated or allylated compounds, cresol novolac resins, phenol aralkyl (including phenylene and biphenylene skeletons) resins, naphthol aralkyl resins, triphenol methane resins, dicyclopentadiene-type phenolic resins, etc. and combinations of these can be used.
- acid anhydrides the following can be used: tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, methylnagic anhydride, hydrogenated methylnagic anhydride, trialkyl tetrahydrophthalic anhydride, methylcyclohexene tetracarboxylic dianhydride, phthalic anhydride, trimellitic anhydride, pyromellitic anhydride, benzophenone tetracarboxylic dianhydride, ethylene glycol bis-anhydritrimellitate, glycerin bis-(anhydro trimellitate) monoacetate, dodecenyl succinic anhydride, aliphatic dibasic acid polyanhydride, chlorendic anhydride, methylbutenyltetrahydrophthalic anhydride, alkylated tetrahydrophthalic anhydride,
- thiol-based curing agents aliphatic polythiol compounds, aromatic polythiol compounds, thiol-modified reactive silicone oil compounds, and the like, and a combination thereof can be used.
- the equivalent ratio of the active group of the (C) curing agent to the epoxy group of the (A) epoxy resin is preferably 0.05 to 1.5, and is more preferably 0.1 to 1.2.
- a method of producing the resin composition of the present invention is not particularly limited, but the resin composition of the present invention can be obtained, for example, by stirring, melting, mixing, and dispersing the (A) epoxy resin, the (B) latent curing catalyst, and the additives that may be used as necessary, either simultaneously or separately, with heat treatment applied as necessary.
- Devices for mixing, stirring, dispersing, etc. for these are not particularly limited, but a Rycai machine equipped with stirring and heating devices, three-roll mill, ball mill, planetary mixer, bead mill, etc. can be used. A combination of these devices may also be used as appropriate.
- the (B) latent curing catalyst does not cause a curing reaction of the (A) epoxy resin at ordinary temperature, so the resin composition of the present invention has good storage stability at ordinary temperature and a long pot life.
- the (B) latent curing catalyst in the resin composition of the present invention can be activated by heating to a temperature of 60° C. or higher, preferably 70° C. or higher, more preferably 80° C. or higher, for example, to activate the curing accelerator in the (B) latent curing catalyst and cause a curing reaction of the (A) epoxy resin.
- Conventional latent curing catalysts which consist of intercalating a curing accelerator into crystalline zirconium phosphate, can only perform the curing reaction at high temperatures above 100° C. (see, for example, Japanese Patent Application Kokai Publication No. 2014-101397). It is believed that the low crystallinity of the zirconium phosphate fine particles containing the curing accelerator makes it easy for the curing accelerator intercalated between the layers to be activated, and that the curing accelerator can be activated even by thermal stimulation at low temperatures of less than 100° C., enabling the curing reaction to take place at low temperatures.
- the resin composition of the present invention is suitable as a one-component adhesive for use in the manufacture of image sensor modules and electronic components, since it can be bonded by heating to a temperature of, for example, 60° C. or higher, preferably 70° C. or higher, more preferably 80° C. or higher.
- the resin composition of the present invention progresses without problems in the curing reaction at high temperatures, and the upper limit of the curing temperature is, for example, 200° C. or lower, preferably 180° C. or lower, and more preferably 150° C. or lower.
- the zirconium phosphate fine particles containing the curing accelerator in the (B) latent curing catalyst of the present invention are very small, with an average particle diameter of 1 nm to 500 nm, so they can penetrate into narrow gaps. Therefore, the resin composition of the present invention can be used for bonding and sealing of narrow gaps, and is useful as an adhesive and sealing material used in the manufacture of semiconductor devices.
- an adhesive containing the resin composition of the second embodiment above is also an embodiment of the present invention.
- film-form adhesives have been widely used as adhesives for die bonding, interlayer bonding, and semiconductor encapsulation, which are advantageous for downsizing and miniaturization of support members. Since the average particle diameter of the included zirconium phosphate particulates containing the curing accelerator is very small, ranging from 1 nm to 500 nm, the resin composition can be made into a film with a thickness of 1 ⁇ m or less, making it highly useful when a thin layer film-form adhesive is required. Therefore, a film containing the resin composition of the second embodiment is also an embodiment of the present invention.
- the cured product obtained by curing the resin composition of the present invention is also an embodiment of the present invention.
- the method for producing the cured product includes a step of curing the resin composition.
- the curing of the resin composition can be performed, for example, by heating to a temperature of 60° C. or higher, preferably 70° C. or higher, more preferably 80° C. or higher.
- the heating time is not particularly limited, but can be from about 30 minutes to 24 hours.
- the resin compositions or cured products of the present invention can be used in various fields such as for paints, civil engineering and construction, electrical, transportation equipment, medical, packaging, textiles, and sports and leisure.
- metals, glass, plastics, mortar, concrete, rubber, wood, leather, cloth, and paper are examples of adherends to which the epoxy resin composition or epoxy resin cured product of the present invention can be applied.
- zirconium propionate dissolved in 10 ml of ethanol, 1.2 ml (17.6 mmol) of phosphoric acid was added little by little and stirred vigorously. After a few minutes, zirconium phosphate fine particles were obtained as a transparent gel-like substance. The obtained gel-like zirconium phosphate fine particles were washed three times (4000 rpm ⁇ 3 min) with ethanol and then solvent replaced three times (4000 rpm ⁇ 3 min) with toluene.
- Powder X-ray diffraction patterns of zirconium phosphate fine particles containing the curing accelerator were measured by an X-ray diffractometer (from Rigaku Corporation) using CuK ⁇ radiation.
- the zirconium phosphate fine particles containing the curing accelerator with the solvent were measured under the following X-ray powder diffraction conditions.
- the zirconium phosphate fine particles containing the curing accelerator with the solvent removed were measured under the following X-ray powder diffraction conditions.
- FIG. 1 Powder X-ray diffraction patterns of zirconium phosphate fine particles containing the curing accelerator are shown in FIG. 1 .
- FIG. 1-1 is a powder X-ray diffraction pattern of zirconium phosphate fine particles containing the curing accelerator with the solvent.
- FIG. 1-2 is a powder X-ray diffraction pattern of zirconium phosphate fine particles containing the curing accelerator with the solvent removed.
- TEM photographs of zirconium phosphate fine particles containing the curing accelerator were taken using a transmission electron microscope (TEM) (from FEI Company, model number: Titan Cubed G2 60-300) in an arbitrary range of about 400 nm ⁇ 600 nm. The average value when the particle diameter of the plate surface of 20 particles (long axis length of the plate surface) was measured was used as an average particle diameter. The average particle diameter of zirconium phosphate fine particles containing the curing accelerator was 20 nm by TEM observation. The TEM photograph of zirconium phosphate fine particles containing the curing accelerator is shown in FIG. 2 .
- TEM transmission electron microscope
- Each resin composition was prepared by mixing the following components in the proportions of each of Examples 1 to 4 and Comparative Examples 1 to 4 listed in Table 1, and then removing the solvent using a vacuum dryer for 6 hours at ordinary temperature.
- the (B) latent curing catalyst the (B) latent curing catalyst containing the solvent was mixed with the resin composition, followed by vacuum drying of the entire resin composition to remove the solvent in the (B) latent curing catalyst.
- the percentages of the respective components shown in Table 1 are all expressed in parts by mass, and a blank column means that the component is not blended.
- the “amine content (g)” listed in Table 1 is a content of amine in each resin composition, where this amine is the amine in the dried (B) and (B′). This amine content was calculated based on the amount of nitrogen atoms relative to the mass of dried (B) and (B′), based on the results of elemental analysis using elemental analyzer 240011 from PerkinElmer Inc.
- the zirconium phosphate fine particles containing the curing accelerator produced in Example A above were used.
- Table 1 the masses listed outside the parentheses are the masses for those containing the solvent before solvent removal, and the masses listed in the parentheses are the masses for those after solvent removal.
- the particles were produced using 2-ethyl-4-methylimidazole as amine according to the method described in Japanese Patent Application Kokai Publication No. 2014-101397.
- the powder X-ray diffraction pattern is shown in FIG. 3 .
- the measurement conditions for X-ray powder diffraction are as follows.
- Each curing property of the prepared epoxy resin compositions was evaluated by dropping a drop of the respective resin compositions to form a hemispherical sample and then observing the state of the sample when it was heated at 150° C., 120° C., 100° C., and 80° C. for one hour.
- the measurement results are shown in Table 1 below.
- Table 1 When the hemispherical sample was solid and had no tack, it was judged to be sufficiently cured and marked ⁇ ; when the hemispherical sample was solid but had tack, it was judged to be cured to some extent and marked ⁇ ; and when the hemispherical sample did not become solid, it was judged to be uncured and marked x.
- the viscosity (Pa ⁇ s) at 25° C. was measured at 50 rpm using a rotational viscometer HBDV-1 (using spindle SC4-14) from Brookfield, and was used as an initial viscosity.
- the each epoxy resin composition was placed in a sealed container and stored at 25° C.
- the viscosity at the end of 0, 6, and 30 hours was measured using the same procedure, and the thickening ratio (thickening ratio after storage for 0, 6, and 30 hours), which is an index of pot life, was determined.
- the measurement results are shown in Table 1 below. For pot life, it is desirable that the post-storage thickening ratio is 2 times or less.
- the resin compositions of Examples 1 to 4 containing the latent curing catalyst of the present invention showed good curing property at all curing temperatures of 80° C., 100° C., 120° C. and 150° C.
- the resin compositions of Comparative Examples 1 to 4 which did not contain the latent curing catalyst of the present invention and contained amine-containing zirconium phosphate crystalline particles of the conventional product, all failed to cure at a curing temperature of 80° C.
- the resin compositions of Examples 1 to 4 also had excellent pot life as well as the conventional products.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Epoxy Resins (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
- The present invention relates to a latent curing catalyst, a resin composition containing the catalyst, and a method for producing zirconium phosphate fine particles containing a curing accelerator.
- Alpha-zirconium phosphate (α-ZrP) forms a layered structure by cross-linking phosphates pairs above and below the zirconium atom surface. It is known that zirconium phosphate can intercalate basic compounds such as amine compounds into the interlayer by utilizing the properties of the phosphate groups in the interlayer as solid acids (see, for example, Non-Patent Documents 1 and 2).
- A curing accelerator that has the characteristic that a mixture of epoxy resin and curing accelerator can be stored under room temperature conditions, and that becomes active and progresses in curing only when curing by an external stimulus such as heat or light, is called a latent curing catalyst. Various types of latent curing catalysts have been developed, and it has been reported that an amine compound used as an epoxy resin curing accelerator is intercalated between the layers of layered zirconium phosphate to be used as a latent curing catalyst that does not react with the resin under one-component storage conditions, i.e., the reaction does not proceed under storage conditions and is inactive, but proceeds only under heating conditions (see, for example, Patent Documents 1 to 5).
-
- Patent Document 1: Japanese Patent Application Kokai Publication No. 2014-101397
- Patent Document 2: Japanese Patent Application Kokai Publication No. H09-003166
- Patent Document 3: Japanese Patent Application Kokai Publication No. H07-149874
- Patent Document 4: Japanese Patent Application Kokai Publication No. H07-25989
- Patent Document 5: Japanese Patent Application Kokai Publication No. H06-025388
-
- Non-Patent Document 1: R. M. Tindwa, D. K. Ellis, G. Z. Oeng, A. Clearfield, J. Chem. Soc., Faraday Trans., 81, 545 (1985)
- Non-Patent Document 2: A. Clearfield, R. M. Tinda, J. Inorg. Nucl. Chem., 41, 871 (1979)
- Conventional latent curing catalysts consisting of amine compounds intercalated with zirconium phosphate, such as those described in Patent Documents 1 to 5, have excellent storage stability, but the curing reaction can only be carried out at high temperatures of 100° C. or higher, making them unsuitable for use in materials with low heat resistance. On the other hand, when manufacturing image sensor modules used as camera modules for cell phones and smartphones, one-component adhesives that thermally cure at relatively low temperatures, specifically lower than 100° C., are used. Even during the manufacture of electronic parts such as semiconductor devices, integrated circuits, large-scale integrated circuits, transistors, thyristors, diodes, and capacitors, it may be desirable to use one-component adhesives that thermally cure at temperatures lower than 100° C. Therefore, there is a need for latent curing catalysts and resin compositions that can carry out curing reactions at low temperatures less than 100° C.
- The present invention addresses the problem of providing a latent curing catalyst having excellent storage stability and capable of performing a curing reaction at a low temperature of less than 100° C., and a resin composition containing the catalyst.
- Specific measures to solve the aforementioned problems are as follows.
- The first embodiment of the present invention is a latent curing catalyst including zirconium phosphate fine particles containing a curing accelerator, wherein the zirconium phosphate fine particles containing the curing accelerator do not have a sharp crystalline peak at a diffraction angle (2θ) in a range of 10° to 40° in powder X-ray diffraction and have a broad halo pattern.
- The second embodiment of the present invention is a resin composition containing (A) an epoxy resin and (B) the latent curing catalyst of the first embodiment.
- The third embodiment of the present invention is an adhesive containing the resin composition of the second embodiment.
- The fourth embodiment of the present invention is a film containing the resin composition of the second embodiment.
- The fifth embodiment of the present invention is a cured product obtained by curing the resin composition of the second embodiment.
- The sixth embodiment of the present invention is a method for producing a cured product, including a step of curing the resin composition of the second embodiment.
- The seventh embodiment of the present invention is a method for producing zirconium phosphate fine particles containing a curing accelerator, including:
- (a) dissolving a zirconium salt of a fatty acid or a zirconium alkoxide in a solvent to obtain a solution; and
- (b) mixing the solution obtained in the step (a) with phosphoric acid to obtain zirconium phosphate fine particles; and
- (c) mixing a medium containing the zirconium phosphate fine particles with a curing accelerator to obtain zirconium phosphate fine particles containing the curing accelerator.
- According to the present invention, it is possible to provide a latent curing catalyst having excellent storage stability and capable of performing curing reactions at low temperatures of less than 100° C., a resin composition containing the catalyst, and an adhesive and a film containing the resin composition. The zirconium phosphate fine particles containing the curing accelerator as a latent curing catalyst have a very small average particle diameter, which allows them to penetrate into narrow gaps and can be used for bonding and sealing of narrow gaps. Therefore, according to the present invention, it is possible to provide a latent curing catalyst, a resin composition containing the catalyst, and an adhesive and a film containing the resin composition, which have excellent storage stability, can perform curing reactions at low temperatures of less than 100° C., and can be used for bonding and sealing of narrow gaps. The present invention also provides a method for producing zirconium phosphate fine particles containing a curing accelerator that can be used as a latent curing catalyst that has excellent storage stability and can perform curing reactions at low temperatures of less than 100° C.
-
FIG. 1 shows powder X-ray diffraction patterns of zirconium phosphate fine particles containing a curing accelerator in Example A.FIG. 1-1 shows a powder X-ray diffraction pattern of zirconium phosphate fine particles containing a curing accelerator with solvent.FIG. 1-2 shows a powder X-ray diffraction pattern of zirconium phosphate fine particles containing a curing accelerator with the solvent removed. -
FIG. 2 shows a TEM photograph of zirconium phosphate fine particles containing a curing accelerator in Example A, taken over an arbitrary area of about 400 nm×600 nm. -
FIG. 3 shows a powder X-ray diffraction pattern of amine-containing zirconium phosphate crystalline particles produced according to the method described in Japanese Patent Application Kokai Publication No. 2014-101397. - [Latent Curing Catalyst]
- The first embodiment of the present invention, a latent curing catalyst, is a latent curing catalyst including zirconium phosphate fine particles containing a curing accelerator, wherein the zirconium phosphate fine particles containing the curing accelerator do not have a sharp crystalline peak at a diffraction angle (2θ) in a range of 10° to 40° in powder X-ray diffraction and have a broad halo pattern. In the present invention, zirconium phosphate fine particles containing a curing accelerator can be used directly as a latent curing catalyst. The latent curing catalyst of this embodiment has excellent storage stability and can perform curing reactions at low temperatures of less than 100° C. In addition, since the average particle diameter of the latent curing catalyst is very small, it can penetrate into narrow gaps and can be used for bonding and sealing of narrow gaps.
- [Zirconium Phosphate Fine Particles Containing a Curing Accelerator]
- The zirconium phosphate fine particles containing a curing accelerator in this embodiment have low crystallinity and a broad halo pattern in powder X-ray diffraction without a sharp crystalline peak at a diffraction angle (2θ) in a range of 10° to 40°. For example, it shows a powder X-ray diffraction pattern which is substantially identical to
FIG. 1 . Note, however, that with respect to the powder X-ray diffraction pattern, the diffraction peak intensities in the experimental pattern can be different and may vary due to the preferred orientation in the prepared sample, as is well known in the art. - Conventional layered zirconium phosphate with intercalated curing accelerators between the layers can be obtained, for example, by mixing layered zirconium phosphate with a curing accelerator and reacting at room temperature to 40° C. for 1 hour to 1 month (see, for example, Japanese Patent Application Kokai Publication No. 2014-101397). Zirconium phosphate with a layered structure has a uniform interlayer distance and high crystallinity (see
FIG. 3 ). The particle diameter of zirconium phosphate with a layered structure can be controlled by its production method, and the particle diameter on the plate surface is usually 1 μm to 100 μm (in addition, zirconium phosphate with a layered structure usually takes the form of flat particles). Zirconium phosphate with a layered structure can be produced, for example, by mixing and reacting zirconium chloride octahydrate with an aqueous phosphoric acid solution (L. Sun, W. J. Boo, H.-J. Sue, A. Clearfield, New J. Chem., 31, 39 (2007)). - The zirconium phosphate fine particles containing a curing accelerator in the present invention can be obtained by mixing zirconium phosphate fine particles with the curing accelerator. In the series of reactions to obtain zirconium phosphate fine particles containing a curing accelerator in the present invention, the external temperature is not limited, and for example, it can be carried out at room temperature to 40° C. Unlike conventional methods of producing zirconium phosphate with a layered structure, zirconium phosphate fine particles can be obtained, for example, by dissolving a zirconium salt of a fatty acid or a zirconium alkoxide in a solvent to obtain a solution, and then mixing the solution with phosphoric acid. Although the zirconium phosphate fine particles obtained in this way have a layered structure, their interlayer distance is wide, their crystallinity is low, and their average particle diameter is 1 nm to 500 nm. It is thought that the low crystallinity of the zirconium phosphate fine particles in the zirconium phosphate fine particles containing a curing accelerator in the present invention makes it easy for the curing accelerator intercalated between the layers to be activated, and for example, even low-temperature thermal stimulation of 60° C. or higher, preferably 70° C. or higher, and more preferably 80° C. or higher activates the curing accelerator, allowing the curing reaction to take place at low temperatures. In addition, the zirconium phosphate fine particles containing a curing accelerator in the present invention have a very small average particle diameter of 1 nm to 500 nm, so they can penetrate into narrow gaps and can be used for bonding and sealing of narrow gaps.
- The method for producing zirconium phosphate fine particles containing a curing accelerator in the present invention includes the following steps:
- (a) dissolving a zirconium salt of a fatty acid or a zirconium alkoxide in a solvent to obtain a solution;
- (b) mixing the solution obtained in the step (a) with phosphoric acid to obtain zirconium phosphate fine particles; and
- (c) mixing a medium containing the zirconium phosphate fine particles with a curing accelerator to obtain zirconium phosphate fine particles containing the curing accelerator. A method for producing zirconium phosphate fine particles containing a curing accelerator is an embodiment of the present invention.
- First, (a) a zirconium salt of a fatty acid or a zirconium alkoxide is dissolved in a solvent to obtain a solution. The zirconium salt of fatty acid is zirconium salts of fatty acids, and can be zirconium salts of mono-fatty acids or zirconium salts of poly-fatty acids such as di-fatty acids. The fatty acids are preferably fatty acids with 1 to 6 carbon atoms, such as acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, valeric acid, caproic acid, and lactic acid. Among these, the zirconium salt of fatty acid is preferably zirconium propionate.
- The zirconium alkoxide is represented by the formula:
-
Zr—(OR1)4 or O═Zr(OR1)2 - wherein R1 is independently methyl, ethyl, n-propyl, i-propyl, n-butyl, and tert-butyl.
- Solvents can be any solvents in which zirconium salts of fatty acids or zirconium alkoxides can be dissolved, and examples thereof may include alcohols such as methanol, ethanol, propanol, and butanol; esters such as ethyl acetate and methyl acetate; ketones such as acetone and 2-butanone; ethers such as diethyl ether, dimethyl ether, diisopropyl ether, and tetrahydrofuran; amides such as dimethylformamide and dimethylacetamide; dimethyl sulfoxide, N-methylpyrrolidone, acetonitrile, chloroform, dichloromethane, etc.; and mixtures of these solvents. Of these, alcohols or esters are preferred.
- Next, (b) the solution obtained in the step (a) above is mixed with phosphoric acid to obtain zirconium phosphate fine particles. The molar ratio of zirconium to phosphoric acid in zirconium phosphate fine particles can be adjusted depending on the amount of phosphoric acid used, and the amount of phosphoric acid used is, for example, 1 mol or more, preferably 2 mol or more, and 10 mol or less, preferably 7 mol or less with respect to 1 mol of zirconium salt of fatty acid or zirconium alkoxide.
- The mixing of the solution obtained in the step (a) with phosphoric acid is performed, for example, by adding phosphoric acid to the solution obtained in the step (a) and stirring. As soon as the solution obtained in the step (a) is mixed with phosphoric acid, zirconium phosphate fine particles are precipitated as a transparent gel-like substance. The precipitated zirconium phosphate fine particles contain the solvent used for production. If necessary, the precipitated zirconium phosphate fine particles may be washed and the aforementioned solvent may be replaced with other solvents. In addition to the solvents used in the step (a), alkanes such as hexane and heptane, and aromatic hydrocarbons such as benzene and toluene can be used as other solvents that can be used for washing and replacement. Here, the solvent containing zirconium phosphate fine particles can be used as a medium containing zirconium phosphate fine particles used in the next step (c).
- Next, (c) a medium containing the zirconium phosphate fine particles and a curing accelerator are mixed to obtain zirconium phosphate fine particles containing the curing accelerator. The mixing of the medium containing the zirconium phosphate fine particles and the curing accelerator can be performed, for example, by adding the curing accelerator dissolved in a solvent to the medium containing the zirconium phosphate fine particles and stirring for 30 minutes to 24 hours. In addition to the solvents used in the step (a), alkanes such as hexane and heptane, and aromatic hydrocarbons such as benzene and toluene can be used as solvents to dissolve the curing accelerator, but preferably the same medium as the medium containing the zirconium phosphate fine particles is used. After completion of the reaction, the zirconium phosphate fine particles containing the curing accelerator can be obtained by separating from the medium and washing with an appropriate solvent. In this state, the zirconium phosphate fine particles containing the curing accelerator are a gel-like substance containing a solvent, and the solvent in the zirconium phosphate fine particles containing the curing accelerator can be removed by drying if necessary. Zirconium phosphate fine particles containing a curing accelerator can be used as a latent curing catalyst in either the solvent-containing state or the solvent-removed state.
- Zirconium phosphate fine particles can contain curing accelerators, usually up to one equivalent of saturation with respect to one equivalent of phosphate groups in zirconium phosphate fine particles. Therefore, when mixing the medium containing zirconium phosphate fine particles and the curing accelerator, the amount of curing accelerator used is preferably 0.5 to 1.5 equivalents with respect to one equivalent of phosphate group of zirconium phosphate fine particles. This can produce a latent curing catalyst that contains 1 to 50% by mass of the curing accelerator. For example, if the curing accelerator is an amine compound, the content (% by mass) of the amine compound in the latent curing catalyst can be calculated by determining the mass of nitrogen atoms contained in the dried latent curing catalyst using an elemental analyzer. Specifically, the content of the amine compound in the latent curing catalyst can be estimated by the following equation: (% by mass)=(mass percentage of nitrogen atoms in the elemental analysis results (% by mass)/(atomic weight of nitrogen [g/mol]×number of nitrogen atoms in the amine compound [units]))×molecular weight of the amine compound [g/mol].
- The detailed conditions of the above steps (a) through (c) may be modified empirically.
- The curing accelerator in zirconium phosphate fine particles containing the curing accelerator is one that lowers the activation energy of the curing reaction of epoxy resins, and any compound known as a curing accelerator for epoxy resins can be used. Of these, curing accelerators with basic properties are preferred because they have a greater effect on the storage stability of the resin composition. Preferred examples of curing accelerators may include imidazole compounds such as imidazole, 2-methylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, 2-phenylimidazole, benzimidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-methylimidazole, 1-benzyl-2-phenylimidazole, 1-cyano-2-methylimidazole, 1-cyano-2-undecylimidazole, 1-cyano-2-ethyl-4-methylimidazole, 1-cyano-2-phenylimidazole, 2,4-diamino-6-[2′-methylimidazolyl-(1′)]-ethyl-s-triazine, 2,4-diamino-6-[2′-undecylimidazolyl-(1′)]-ethyl-s-triazine, 2,4-diamino-6-[2′-ethyl-4′-methylimidazolyl-(1′)]-ethyl-s-triazine, 2-phenyl-4,5-dihydroxymethylimidazole, 2-phenyl-4-methyl-5-dihydroxymethylimidazole, 1,2-trimethylenebenzoimidazole, I-dodecyl-2-methyl-3-benzylimidazole, 2-phenylimidazoline, benzimidazole, and 2-methylbenzimidazole; epoxy-imidazole adducts, which are adducts of these imidazole compounds with epoxy resins; tertiary amine compounds such as trisdimethylaminophenol, 2-(dimethylaminomethyl)phenol, trisdimethylaminomethylphenol, triethanolamine, benzyldimethylamine, hexamethylenetetramine, triethylenediamine, quinoline, N-methylmorpholine, dimethylaniline, dimethylcyclohexylamine, 1,8-diazabicyclo(5,4,0)-7-undecen-7 (DBU), 1,5-diazabicyclo(4,3,0)-5-nonene (DBN), 1,1,3,3-tetramethylguazinine, and 1,4-diaza-bicyclo(2,2,2)octane (DABCO); and triphenylphosphine (TPP), and the like. Among these, imidazole compounds and tertiary amine compounds are more preferred because they can be used to easily obtain excellent physical properties of the cured product, such as heat resistance and electrical properties. These can be used alone or in combination of two or more types.
- The curing accelerator in the present invention is preferably a curing accelerator having a basic property, more preferably imidazole compounds, and even more preferably 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, and 2-methylimidazole.
- The zirconium phosphate fine particles containing the curing accelerator in this embodiment have an average particle diameter of the primary particles of 1 nm to 500 nm, preferably 5 nm to 450 nm, and more preferably 10 nm to 400 nm. As used herein, the average particle diameter of zirconium phosphate fine particles containing a curing accelerator is the average value obtained when the particle diameter of a plate surface (long axis length of the plate surface) of each of 20 arbitrary particles is measured by transmission electron microscopy (TEM). The shape of the zirconium phosphate fine particles containing the curing accelerator is not particularly limited, but usually takes the form of flat particles.
- The zirconium phosphate fine particles containing the curing accelerator of the present invention contain some zirconium salts of fatty acids or zirconium alkoxides used as raw materials in their manufacture. This is thought to cause the interlayer distance of zirconium phosphate fine particles to become uneven and wide, resulting in low crystallinity. The amount of zirconium salts of fatty acids or zirconium alkoxides in the zirconium phosphate fine particles containing the curing accelerator is, for example, 0.01 mol to 0.8 mol, preferably 0.05 mol to 0.5 mol, with respect to 1 mol of zirconium in the zirconium phosphate fine particles. The presence and amount of zirconium salts of fatty acids or zirconium alkoxides in the zirconium phosphate fine particles containing the curing accelerator can be determined by, for example, time-of-flight secondary ion mass spectrometry (TOF-SIMS) or magic angle spinning (MAS) nuclear magnetic resonance spectroscopy (NMR).
- [Resin Composition]
- The second embodiment of the present invention, a resin composition, is a one-component epoxy resin composition containing (a) an epoxy resin and (b) the latent curing catalyst of the first embodiment.
- (A) Epoxy Resin
- The epoxy resin in the present invention is one in which one carbon atom of the epoxy ring is a primary carbon atom from the viewpoint of reactivity with curing accelerators. The epoxy resin is preferably liquid at ordinary temperature (25° C.±5° C.). However, it is also possible to dilute the epoxy resin, which is solid at ordinary temperature, with a diluent or the like to make it liquid for use.
- Specifically, the (A) epoxy resin can be either a monoepoxy compound, a polyvalent epoxy compound, or a mixture thereof. Monoepoxy compounds may include, for example, glycidylbutyl ether, glycidylhexyl ether, glycidylphenyl ether, glycidylallyl ether, glycidyl para-tert-butylphenyl ether, ethylene oxide, propylene oxide, paraxylyl glycidyl ether, glycidyl acetate, glycidyl butyrate, glycidyl hexoate, glycidyl benzoate, and the like. Polyvalent epoxy compounds may include, for example, bisphenol type epoxy resins made by glycidylating bisphenols such as bisphenol A, bisphenol F, bisphenol AD, bisphenol S, tetramethylbisphenol A, tetramethylbisphenol F, tetramethylbisphenol AD, tetramethylbisphenol S, tetrabromobisphenol A, tetrachlorobisphenol A, and tetrafluorobisphenol A; epoxy resins made by glycidylating other divalent phenols such as biphenol, dihydroxynaphthalene, and 9,9-bis(4-hydroxyphenyl)fluorene; epoxy resins made by glycidylating trisphenols such as 1,1,1-tris(4-hydroxyphenyl)methane, and 4,4-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; epoxy resins made by glycidylating tetrakisphenols such as 1,1,2,2,-tetrakis(4-hydroxyphenyl)ethane; .novolac type epoxy resins made by glycidylating novolacs such as phenol novolac, cresol novolac, bisphenol A novolac, brominated phenol novolac, and brominated bisphenol A novolac; epoxy resins made by glycidylating polyhydric phenols; aliphatic ether type epoxy resins made by glycidylating polyhydric alcohols such as glycerin and polyethylene glycol; .ether ester type epoxy resins made by glycidylating hydroxycarboxylic acids such as p-oxybenzoic acid and β-oxynaphthoic acid; ester type epoxy resins made by glycidylating polycarboxylic acids such as phthalic acid and terephthalic acid; glycidyl type epoxy resins, such as glycidylated amine compounds such as 4,4-diaminodiphenylmethane and m-aminophenol, and amine-type epoxy resins such as triglycidyl isocyanurate; and the like. In the present invention, bisphenol type epoxy resins are preferred. Any one of the epoxy resins described above may be used, or two or more may be used in combination.
- The content of the (A) epoxy resin in the resin composition of the present invention is preferably 2 to 80% by mass, more preferably 2.5 to 70% by mass, and even more preferably 3 to 60% by mass. When the content of the (A) epoxy resin in the resin composition is within the above-described range, the desired cured product can be obtained.
- (B) Latent Curing Catalyst
- A (B) latent curing catalyst in the resin composition of the second embodiment of the present invention is the latent curing catalyst of the first embodiment of the present invention.
- The curing accelerator in the (B) latent curing catalyst is preferably a curing accelerator having basic properties, more preferably imidazole compounds, and even more preferably 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, and 2-methylimidazole.
- The amount of the (B) latent curing catalyst (in a solvent-free state) in the epoxy resin composition is preferably 0.1 to 50% by mass, more preferably 1 to 45% by mass, and particularly preferably 3 to 40% by mass, with respect to the total of 100 parts by mass of components other than solid components such as fillers and pigments.
- In addition to the (A) epoxy resin and the (B) latent curing catalyst, the resin composition of the present invention may contain additives as necessary to the extent that the effects of the present invention are not impaired. Additives may include, for example, (C) a curing agent other than the (B) latent curing catalyst, a filler, a diluent, a solvent, a pigment, a flexibility-adding agent, a coupling agent, an antioxidant, a thixotropic agent, and a dispersing agent.
- The resin composition of the present invention can contain (C) a curing agent other than the (B) latent curing catalyst to the extent that the effects of the present invention are not impaired. As the (C) curing agent other than the (B) latent curing catalyst, phenol type curing agents, acid anhydrides, and thiol type curing agents are mentioned.
- Phenol type curing agents refer to monomers, oligomers, and polymers in general that have phenolic hydroxyl groups. Specifically, phenol novolac resins and their alkylated or allylated compounds, cresol novolac resins, phenol aralkyl (including phenylene and biphenylene skeletons) resins, naphthol aralkyl resins, triphenol methane resins, dicyclopentadiene-type phenolic resins, etc. and combinations of these can be used.
- As acid anhydrides, the following can be used: tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, methylnagic anhydride, hydrogenated methylnagic anhydride, trialkyl tetrahydrophthalic anhydride, methylcyclohexene tetracarboxylic dianhydride, phthalic anhydride, trimellitic anhydride, pyromellitic anhydride, benzophenone tetracarboxylic dianhydride, ethylene glycol bis-anhydritrimellitate, glycerin bis-(anhydro trimellitate) monoacetate, dodecenyl succinic anhydride, aliphatic dibasic acid polyanhydride, chlorendic anhydride, methylbutenyltetrahydrophthalic anhydride, alkylated tetrahydrophthalic anhydride, methythymic anhydride, succinic anhydride substituted with alkenyl groups, glutaric anhydride, and the like, and a combination thereof.
- As thiol-based curing agents, aliphatic polythiol compounds, aromatic polythiol compounds, thiol-modified reactive silicone oil compounds, and the like, and a combination thereof can be used.
- When the (C) curing agent other than the (B) latent curing catalyst is included, with respect to the amount of the (C) curing agent, the equivalent ratio of the active group of the (C) curing agent to the epoxy group of the (A) epoxy resin is preferably 0.05 to 1.5, and is more preferably 0.1 to 1.2.
- A method of producing the resin composition of the present invention is not particularly limited, but the resin composition of the present invention can be obtained, for example, by stirring, melting, mixing, and dispersing the (A) epoxy resin, the (B) latent curing catalyst, and the additives that may be used as necessary, either simultaneously or separately, with heat treatment applied as necessary. Devices for mixing, stirring, dispersing, etc. for these are not particularly limited, but a Rycai machine equipped with stirring and heating devices, three-roll mill, ball mill, planetary mixer, bead mill, etc. can be used. A combination of these devices may also be used as appropriate.
- In the resin composition of the present invention, the (B) latent curing catalyst does not cause a curing reaction of the (A) epoxy resin at ordinary temperature, so the resin composition of the present invention has good storage stability at ordinary temperature and a long pot life. The (B) latent curing catalyst in the resin composition of the present invention can be activated by heating to a temperature of 60° C. or higher, preferably 70° C. or higher, more preferably 80° C. or higher, for example, to activate the curing accelerator in the (B) latent curing catalyst and cause a curing reaction of the (A) epoxy resin. Conventional latent curing catalysts, which consist of intercalating a curing accelerator into crystalline zirconium phosphate, can only perform the curing reaction at high temperatures above 100° C. (see, for example, Japanese Patent Application Kokai Publication No. 2014-101397). It is believed that the low crystallinity of the zirconium phosphate fine particles containing the curing accelerator makes it easy for the curing accelerator intercalated between the layers to be activated, and that the curing accelerator can be activated even by thermal stimulation at low temperatures of less than 100° C., enabling the curing reaction to take place at low temperatures. Therefore, the resin composition of the present invention is suitable as a one-component adhesive for use in the manufacture of image sensor modules and electronic components, since it can be bonded by heating to a temperature of, for example, 60° C. or higher, preferably 70° C. or higher, more preferably 80° C. or higher. The resin composition of the present invention progresses without problems in the curing reaction at high temperatures, and the upper limit of the curing temperature is, for example, 200° C. or lower, preferably 180° C. or lower, and more preferably 150° C. or lower.
- In addition, the zirconium phosphate fine particles containing the curing accelerator in the (B) latent curing catalyst of the present invention are very small, with an average particle diameter of 1 nm to 500 nm, so they can penetrate into narrow gaps. Therefore, the resin composition of the present invention can be used for bonding and sealing of narrow gaps, and is useful as an adhesive and sealing material used in the manufacture of semiconductor devices.
- Therefore, an adhesive containing the resin composition of the second embodiment above is also an embodiment of the present invention.
- In recent years, film-form adhesives have been widely used as adhesives for die bonding, interlayer bonding, and semiconductor encapsulation, which are advantageous for downsizing and miniaturization of support members. Since the average particle diameter of the included zirconium phosphate particulates containing the curing accelerator is very small, ranging from 1 nm to 500 nm, the resin composition can be made into a film with a thickness of 1 μm or less, making it highly useful when a thin layer film-form adhesive is required. Therefore, a film containing the resin composition of the second embodiment is also an embodiment of the present invention.
- [Cured Product]
- The cured product obtained by curing the resin composition of the present invention is also an embodiment of the present invention. The method for producing the cured product includes a step of curing the resin composition. The curing of the resin composition can be performed, for example, by heating to a temperature of 60° C. or higher, preferably 70° C. or higher, more preferably 80° C. or higher. The heating time is not particularly limited, but can be from about 30 minutes to 24 hours.
- In addition to the adhesives and films, the resin compositions or cured products of the present invention can be used in various fields such as for paints, civil engineering and construction, electrical, transportation equipment, medical, packaging, textiles, and sports and leisure. For example, metals, glass, plastics, mortar, concrete, rubber, wood, leather, cloth, and paper are examples of adherends to which the epoxy resin composition or epoxy resin cured product of the present invention can be applied.
- The invention will be described in more detail by means of examples and comparative examples, but the invention is not limited to these examples. Unless otherwise stated, preparation and evaluation were carried out at ordinary temperature (25° C.±5° C.).
- [Preparation of Zirconium Phosphate Fine Particles Containing Curing Accelerators]
- To 0.838 g of zirconium propionate dissolved in 10 ml of ethanol, 1.2 ml (17.6 mmol) of phosphoric acid was added little by little and stirred vigorously. After a few minutes, zirconium phosphate fine particles were obtained as a transparent gel-like substance. The obtained gel-like zirconium phosphate fine particles were washed three times (4000 rpm×3 min) with ethanol and then solvent replaced three times (4000 rpm×3 min) with toluene. To the gel-like zirconium phosphate fine particles containing toluene, a solution of 1.20 g (10.9 mmol) of 2-ethyl-4-methylimidazole dissolved in 10.7 mL of toluene was added and stirred for 1 hour. After completion of the reaction, the particles were washed three times (4000 rpm×3 min) with toluene to obtain 9.99 g of zirconium phosphate fine particles containing the curing accelerator as a gel-like substance containing the solvent.
- Powder X-ray diffraction patterns of zirconium phosphate fine particles containing the curing accelerator were measured by an X-ray diffractometer (from Rigaku Corporation) using CuKα radiation.
- The zirconium phosphate fine particles containing the curing accelerator with the solvent were measured under the following X-ray powder diffraction conditions.
- Scanning rate: 10.0 deg/min.
- Target: CuKα.
- Voltage: 40 kV.
- Current: 40 mA.
- Scanning range: 3 to 40.0 degrees.
- Sampling width: 0.100 degrees.
- The zirconium phosphate fine particles containing the curing accelerator with the solvent removed were measured under the following X-ray powder diffraction conditions.
- Scanning rate: 2.00 deg/min.
- Target: CuKα.
- Voltage: 40 kV.
- Current: 40 mA.
- Scanning range: 3 to 40.0 degrees.
- Sampling width: 0.0200 degrees.
- Powder X-ray diffraction patterns of zirconium phosphate fine particles containing the curing accelerator are shown in
FIG. 1 .FIG. 1-1 is a powder X-ray diffraction pattern of zirconium phosphate fine particles containing the curing accelerator with the solvent.FIG. 1-2 is a powder X-ray diffraction pattern of zirconium phosphate fine particles containing the curing accelerator with the solvent removed. - TEM photographs of zirconium phosphate fine particles containing the curing accelerator were taken using a transmission electron microscope (TEM) (from FEI Company, model number: Titan Cubed G2 60-300) in an arbitrary range of about 400 nm×600 nm. The average value when the particle diameter of the plate surface of 20 particles (long axis length of the plate surface) was measured was used as an average particle diameter. The average particle diameter of zirconium phosphate fine particles containing the curing accelerator was 20 nm by TEM observation. The TEM photograph of zirconium phosphate fine particles containing the curing accelerator is shown in
FIG. 2 . - [Preparation of Resin Composition]
- Each resin composition was prepared by mixing the following components in the proportions of each of Examples 1 to 4 and Comparative Examples 1 to 4 listed in Table 1, and then removing the solvent using a vacuum dryer for 6 hours at ordinary temperature. For the (B) latent curing catalyst, the (B) latent curing catalyst containing the solvent was mixed with the resin composition, followed by vacuum drying of the entire resin composition to remove the solvent in the (B) latent curing catalyst. The percentages of the respective components shown in Table 1 are all expressed in parts by mass, and a blank column means that the component is not blended. The “amine content (g)” listed in Table 1 is a content of amine in each resin composition, where this amine is the amine in the dried (B) and (B′). This amine content was calculated based on the amount of nitrogen atoms relative to the mass of dried (B) and (B′), based on the results of elemental analysis using elemental analyzer 240011 from PerkinElmer Inc.
- Bis-A type epoxy resin-Bis-F type epoxy resin mixture (EXA835LV, from DIC Corporation)
- The zirconium phosphate fine particles containing the curing accelerator produced in Example A above were used. In Table 1, the masses listed outside the parentheses are the masses for those containing the solvent before solvent removal, and the masses listed in the parentheses are the masses for those after solvent removal.
- The particles were produced using 2-ethyl-4-methylimidazole as amine according to the method described in Japanese Patent Application Kokai Publication No. 2014-101397. The powder X-ray diffraction pattern is shown in
FIG. 3 . The measurement conditions for X-ray powder diffraction are as follows. - Scanning rate: 2.00 deg/min.
- Target: CuKα.
- Voltage: 40 kV.
- Current: 40 mA.
- Scanning range: 3 to 40.0 degrees.
- Sampling width: 0.0200 degrees.
- (C1) Liquid phenolic resin (MEH8005, from Meiwa Plastic Industries, Ltd.)
- (C2) Acid anhydride (HN5500, from Hitachi Chemical Company, Ltd.)
- (C3) Thiol resin (PEMP, from SC Organic Chemical Co., Ltd.)
- [Evaluation of Curing Property]
- Each curing property of the prepared epoxy resin compositions was evaluated by dropping a drop of the respective resin compositions to form a hemispherical sample and then observing the state of the sample when it was heated at 150° C., 120° C., 100° C., and 80° C. for one hour. The measurement results are shown in Table 1 below. When the hemispherical sample was solid and had no tack, it was judged to be sufficiently cured and marked ∘; when the hemispherical sample was solid but had tack, it was judged to be cured to some extent and marked Δ; and when the hemispherical sample did not become solid, it was judged to be uncured and marked x.
- [Evaluation of Pot Life]
- For the prepared epoxy resin compositions, the viscosity (Pa·s) at 25° C. was measured at 50 rpm using a rotational viscometer HBDV-1 (using spindle SC4-14) from Brookfield, and was used as an initial viscosity. Next, the each epoxy resin composition was placed in a sealed container and stored at 25° C. The viscosity at the end of 0, 6, and 30 hours was measured using the same procedure, and the thickening ratio (thickening ratio after storage for 0, 6, and 30 hours), which is an index of pot life, was determined. The measurement results are shown in Table 1 below. For pot life, it is desirable that the post-storage thickening ratio is 2 times or less.
-
TABLE 1 Comparative Comparative Comparative Comparative Example 1 Example 2 Example 3 Example 4 Example 1 Example 2 Example 3 Example 4 (A) Epoxy resin 10 5.6 5.2 5.6 10 5.6 5.2 5.6 (B) Latent curing catalyst 10 (1.5) 10 (1.5) 10 (1.5) 10 (1.5) (B′) Amine-containing zirconium 2.8 2.8 2.8 2.8 phosphate crystalline particles (C1) Liquid phenolic resin 4.4 4.4 (C2) Acid anhydride 4.8 4.8 (C3) Thiol resin 4.4 4.4 Amine content (g) 0.54 0.54 0.54 0.54 0.55 0.55 0.55 0.55 Evaluation of curing 150° C. 1 h ∘ ∘ ∘ ∘ x ∘ ∘ ∘ property 120° C. 1 h ∘ ∘ ∘ ∘ x ∘ ∘ ∘ (∘: Cured, Δ: Had tack, 100° C. 1 h ∘ ∘ ∘ ∘ x Δ ∘ ∘ x: Uncured) 80° C. 1 h Δ ∘ ∘ ∘ x x x x Evaluation of pot life 0 h 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 (Initial ratio: times) 6 h 1.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 30 h 1.0 1.1 1.9 1.5 1.0 1.5 1.2 1.1 - As can be seen from the results shown in Table 1, the resin compositions of Examples 1 to 4 containing the latent curing catalyst of the present invention showed good curing property at all curing temperatures of 80° C., 100° C., 120° C. and 150° C. On the other hand, the resin compositions of Comparative Examples 1 to 4, which did not contain the latent curing catalyst of the present invention and contained amine-containing zirconium phosphate crystalline particles of the conventional product, all failed to cure at a curing temperature of 80° C. The resin compositions of Examples 1 to 4 also had excellent pot life as well as the conventional products.
- The disclosure of Japanese Patent Application No. 2019-088045 (filing date: May 8, 2019) is incorporated herein by reference in its entirety.
- All references, patent applications, and technical standards described herein are incorporated herein by reference to the same extent as if the individual references, patent applications, and technical standards were specifically and individually noted as being incorporated by reference.
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019088045A JP7231153B2 (en) | 2019-05-08 | 2019-05-08 | Latent curing catalyst and resin composition containing the same |
JP2019-088045 | 2019-05-08 | ||
PCT/JP2020/017678 WO2020226077A1 (en) | 2019-05-08 | 2020-04-24 | Latent curing catalyst and resin composition containing same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220177639A1 true US20220177639A1 (en) | 2022-06-09 |
Family
ID=73044144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/609,365 Abandoned US20220177639A1 (en) | 2019-05-08 | 2020-04-24 | Latent curing catalysts and resin composition containing the same |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220177639A1 (en) |
EP (1) | EP3967729A4 (en) |
JP (1) | JP7231153B2 (en) |
KR (1) | KR20220007073A (en) |
CN (1) | CN113785016A (en) |
TW (1) | TWI841725B (en) |
WO (1) | WO2020226077A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2023058303A1 (en) * | 2021-10-05 | 2023-04-13 | ||
JPWO2023090389A1 (en) * | 2021-11-18 | 2023-05-25 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0193410A (en) * | 1987-10-03 | 1989-04-12 | Advance Co Ltd | Production of zirconium phosphate |
JPH093166A (en) * | 1995-06-22 | 1997-01-07 | Toagosei Co Ltd | Thermosetting epoxy resin composition |
US20040007532A1 (en) * | 2002-07-15 | 2004-01-15 | Bortun Anatoly I. | Zirconium phosphate, hafnium phosphate and method of making same |
CN105129755A (en) * | 2015-09-01 | 2015-12-09 | 南方科技大学 | Method for producing a monolayer of metal phosphate and use thereof |
US20160115324A1 (en) * | 2014-03-25 | 2016-04-28 | Kaneka Corporation | Coating compositions and coating products made therefrom |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4701314A (en) * | 1986-10-29 | 1987-10-20 | International Business Machines Corporation | Method of producing microsized amorphous particles of metal phosphate |
JPH0673162A (en) * | 1992-07-06 | 1994-03-15 | Toagosei Chem Ind Co Ltd | Thermosetting epoxy resin composition |
JPH0625388A (en) | 1992-07-06 | 1994-02-01 | Toagosei Chem Ind Co Ltd | Thermosetting epoxy resin composition |
JP3374453B2 (en) | 1993-07-12 | 2003-02-04 | 東亞合成株式会社 | Thermosetting epoxy resin composition |
JP3374490B2 (en) | 1993-12-01 | 2003-02-04 | 東亞合成株式会社 | Thermosetting epoxy resin composition |
US6749939B2 (en) | 2002-02-19 | 2004-06-15 | Ppg Industries, Ohio, Inc. | Composition having sealing and sound dampening properties and methods related thereto |
JP2011012168A (en) | 2009-07-01 | 2011-01-20 | Enex Co Ltd | Porous fine particle-like latent curing agent and latent curable epoxy composition and latent curable urethane composition using the same |
JP2014101397A (en) | 2012-11-16 | 2014-06-05 | Josho Gakuen | Epoxy resin composition |
JP2019065156A (en) | 2017-09-29 | 2019-04-25 | 大阪ガスケミカル株式会社 | Curing agent-containing particle |
JP6317516B1 (en) | 2017-11-01 | 2018-04-25 | 高周波熱錬株式会社 | DC smoothing circuit, inverter, and power supply device |
-
2019
- 2019-05-08 JP JP2019088045A patent/JP7231153B2/en active Active
-
2020
- 2020-04-24 TW TW109113828A patent/TWI841725B/en active
- 2020-04-24 EP EP20801538.8A patent/EP3967729A4/en active Pending
- 2020-04-24 CN CN202080033381.7A patent/CN113785016A/en active Pending
- 2020-04-24 US US17/609,365 patent/US20220177639A1/en not_active Abandoned
- 2020-04-24 WO PCT/JP2020/017678 patent/WO2020226077A1/en unknown
- 2020-04-24 KR KR1020217037817A patent/KR20220007073A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0193410A (en) * | 1987-10-03 | 1989-04-12 | Advance Co Ltd | Production of zirconium phosphate |
JPH093166A (en) * | 1995-06-22 | 1997-01-07 | Toagosei Co Ltd | Thermosetting epoxy resin composition |
US20040007532A1 (en) * | 2002-07-15 | 2004-01-15 | Bortun Anatoly I. | Zirconium phosphate, hafnium phosphate and method of making same |
US20160115324A1 (en) * | 2014-03-25 | 2016-04-28 | Kaneka Corporation | Coating compositions and coating products made therefrom |
CN105129755A (en) * | 2015-09-01 | 2015-12-09 | 南方科技大学 | Method for producing a monolayer of metal phosphate and use thereof |
Non-Patent Citations (5)
Also Published As
Publication number | Publication date |
---|---|
CN113785016A (en) | 2021-12-10 |
TWI841725B (en) | 2024-05-11 |
EP3967729A4 (en) | 2023-06-14 |
JP2020183473A (en) | 2020-11-12 |
KR20220007073A (en) | 2022-01-18 |
TW202104340A (en) | 2021-02-01 |
WO2020226077A1 (en) | 2020-11-12 |
EP3967729A1 (en) | 2022-03-16 |
JP7231153B2 (en) | 2023-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7927514B2 (en) | Microcapsule-based hardener for epoxy resin, masterbatch-based hardener composition for epoxy resin, one-part epoxy resin composition, and processed good | |
JP5534615B2 (en) | Microcapsule type epoxy resin curing agent, masterbatch type epoxy resin curing agent composition, one-part epoxy resin composition, and processed product | |
CA2601950C (en) | Latent hardener for epoxy resin and epoxy resin composition | |
CN106232608B (en) | Epoxy compound, mixture, composition and cured product containing the same, and preparation method and application thereof | |
US20220177639A1 (en) | Latent curing catalysts and resin composition containing the same | |
JP2009132931A (en) | Capsule type curing agent and composition | |
JP6852039B2 (en) | A method for producing an epoxy compound having an alkoxysilyl group, an epoxy compound having an alkoxysilyl group, a composition containing the same, and its use. | |
JPWO2006008984A1 (en) | Epoxy resin, epoxy resin composition and cured product thereof | |
KR20050030863A (en) | Epoxy compound, preparation method thereof, and use thereof | |
JP6432808B2 (en) | Epoxy resin and its cured product | |
KR101217385B1 (en) | Epoxy resin, epoxy resin composition, and cured object obtained therefrom | |
CN103906753B (en) | Isocyanurate epoxy compound having alkoxysilyl group, method of preparing same, composition including same, cured product of the composition, and use of the composition | |
JP4655490B2 (en) | Epoxy resin composition and cured product thereof | |
JP5368707B2 (en) | Liquid epoxy resin, epoxy resin composition, and cured product | |
JP6505428B2 (en) | Microcapsule type amine curing agent, curable resin composition, fine chemicals and composition | |
JP5220488B2 (en) | Epoxy resin, epoxy resin composition, and cured product thereof | |
JP2004143362A (en) | Epoxy resin composition having low viscosity | |
JPH01110526A (en) | Epoxy resin composition for prepreg | |
JP2010053314A (en) | Thermosetting resin, thermosetting composition, laminate film, and laminate | |
JP6251407B2 (en) | Inclusion compound crystals, method for producing the same, and curable resin composition | |
WO2024150793A1 (en) | Polycrystalline form of biphenol diglycidyl ether, and resin composition containing said polycrystalline form and cured product thereof | |
WO2024135713A1 (en) | Epoxy resin, production method for same, curable resin composition, and cured product | |
TW202321336A (en) | Curable composition, cured product thereof, prepreg, circuit board, build-up film, semiconductor sealing material and semiconductor device | |
WO2022085522A1 (en) | Liquid resin composition and cured object obtained therefrom | |
WO2015125760A1 (en) | Resin-modified filler, epoxy resin composition, and cured product thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NAMICS CORPORATION, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHIMOMURA, OSAMU;IWAYA, KAZUKI;REEL/FRAME:058038/0217 Effective date: 20210908 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |